help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, X.-M.
Right arrow Articles by Aguilera, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, X.-M.
Right arrow Articles by Aguilera, G.
Endocrinology Vol. 140, No. 8 3623-3632
Copyright © 1999 by The Endocrine Society


ARTICLES

Vasopressin and Corticotropin-Releasing Hormone Gene Responses to Novel Stress in Rats Adapted to Repeated Restraint

Xin-Ming Ma1, Stafford L. Lightman and Greti Aguilera

Section on Endocrine Physiology, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health (X.-M.M., G.A.), Bethesda, Maryland 20892; Dorothy Crowfoot Hodgkin Laboratories, Department of Medicine, University of Bristol (S.L.L.), Bristol, United Kingdom BS2 8HW

Address all correspondence and requests for reprints to: Greti Aguilera, M.D., Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Building 10, Room 10N262, Bethesda, Maryland 20892. E-mail: greti{at}helix.nih.gov


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Stress-responsive neurons of the hypothalamic paraventricular nucleus (PVN) show functional plasticity and adapt to repeated restraint (RR) stress. To investigate whether neuronal adaptation to the homotypic stress also affects their response to a heterotypic stressor, we used in situ hybridization with intronic and exonic probes to measure primary transcript (hnRNA) and messenger RNA (mRNA) levels for CRH and vasopressin (VP) in the PVN of control and RR rats after the heterotypic stress of ip hypertonic saline injection (ipHS). Two weeks of daily restraint blunted plasma corticosterone and parvocellular CRH, but not VP, transcript responses to a further restraint episode. IpHS increased circulating corticosterone in both groups, but levels were higher in RR rats. CRH hnRNA increased within 15 min and returned to baseline by 1 h in both naive and RR rats. CRH mRNA increased more slowly in both groups, peaking at 2 h, with RR rats showing greater responses at this time. Parvocellular VP hnRNA reached a peak 2 h after ipHS in naive rats, but more rapidly (1 h) and to higher levels in RR rats. The number of parvocellular neurons expressing VP hnRNA increased approximately 5-fold after ipHS in both groups. Basal VP mRNA levels and the number of parvocellular cells expressing VP mRNA were elevated in RR rats. Both ipHS and naive rats showed an increase in VP mRNA transcripts after ipHS, with RR rats showing greater levels at 2 and 4 h. Magnocellular cells in both PVN and supraoptic nuclei showed increases in VP hnRNA within 15 min. The data demonstrate VP responses in parvocellular neurons of both control and RR rats, whereas profound inhibition of CRH transcription is selective for the homotypic stressor with CRH responsiveness to the heterotypic stress preserved or increased.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
CRH AND vasopressin (VP) synthesized and secreted into the pituitary portal circulation by parvocellular neurons in the paraventricular hypothalamic nucleus (PVN) are the main regulators of ACTH secretion in the pituitary corticotroph (1). Although VP is only a weak ACTH secretagogue on its own, it acts synergistically with CRH and is believed to play an important role in sustaining pituitary responsiveness during chronic stress (1, 2, 3, 4). There are two populations of CRH neurons in the PVN, one in which only CRH can be detected and another in which both CRH and VP coexist (5). Studies based on the levels of immunoreactive peptide and messenger RNA (mRNA) for CRH and VP have suggested that differential regulation of these peptides in the PVN plays an important role in determining the responsiveness of the hypothalamic-pituitary-adrenal axis during chronic stress (1, 2, 3, 4, 5). More recently, the development of in situ hybridization techniques with probes directed against introns has allowed a more detailed analysis of the regulation of CRH and VP gene expression in the PVN (6, 7, 8, 9, 10, 11). As introns are rapidly spliced out, intronic hybridization detects newly transcribed RNA or heteronuclear (hn) RNA, which reflects changes in gene transcription and is a much more sensitive index of neuronal response than measurement of steady state mRNA levels.

Using intronic hybridization, previous studies have shown that transcription of both CRH and VP is activated by acute stress (9, 11, 12, 13, 14, 15, 16), whereas an increased proportion of cells that cosecrete CRH and VP (17, 18, 19) and a preferential activation of VP rather than CRH (10, 11, 18) are observed after repeated stress. Depending on the stress paradigm, repeated stress can result in an adaptation or desensitization of the hypothalamic-pituitary-adrenal (HPA) axis to the homotypic stressor (10, 20, 21, 22, 23). However, exposure of repeatedly stressed animals to a novel stress usually results in a greater ACTH response than that seen in naive control animals (4, 21, 24, 25). In the current studies we have investigated how adaptation of the hypothalamic response to a homotypic stressor affects plasma corticosterone and the hypothalamic CRH and VP hnRNA and mRNA responses to a novel heterotypic stressor.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animal procedures
Adult male Sprague Dawley rats, weighing 250–300 g, were housed three per cage and maintained for at least 5 days before study with a 12-h light-dark cycle and food and water ad libitum. All experimental procedures were performed according to the NIH guidelines, and experimental protocols were approved by the NICHHD animal care and use committee.

Rats were divided into two groups. One group was left undisturbed (naive rats), and a second group was subjected to daily restraint for 60 min for 14 days by placing the rats into 2.5 x 6-in. plastic restrainers. On day 15, 24 h after the last restraint, groups of six rats from each group were killed undisturbed or 15 min, 1 h, 2 h, or 4 h after a novel stress, ipHS (1.5 M NaCl, 1.5 ml/100 g BW), a painful stress paradigm with an osmotic component (26, 27). Additional groups of six naive and repeatedly restrained (RR) rats were subjected to an additional 60-min restraint episode and killed 3 h later. All experimental manipulations were performed between 0900–1200 h.

Rats were killed by decapitation between 0900–1200 h. Trunk blood was collected into ice-cold tubes containing EDTA and centrifuged, and plasma was stored at -20 C for corticosterone RIAs using a rat corticosterone kit (Diagnostic Products, Los Angeles, CA) with a sensitivity of 7.5 ng/ml. Brains were removed, frozen on dry ice, and stored at -80 C. Twelve-micron sections were cut through the medial parvocellular subdivision of the PVN, thaw mounted on poly-L-lysine (Sigma Chemical Co., St. Louis, MO)-coated slides, and stored at -80 C.

In situ hybridization histochemistry
The rat CRH intron (CRHin) probe (supplied by Dr. Robert Thompson, University of Michigan, Ann Arbor, MI) was a 530-bp PvuII fragment of the CRH gene subcloned into pGEM-3 (Promega Corp., Madison, WI) and linearized with XbaI. The rat CRH (CRHex 2) complementary DNA (Dr. Robert Thompson) was a 770-bp BamHI fragment subcloned in pGEM-3Z (Promega Corp.), linearized by HindIII. The VP exonic probe was a 230-bp fragment of exon 3 of the rat VP complementary DNA (VPex) cloned into pGEM-4Z (provided by Drs. Susan Wray and Harold Gainer, NINDS, NIH, Bethesda, MD) and linearized with BamHI. The VP intronic probe (VPin; supplied by Dr. Thomas G. Sherman, Georgetown University, Washington DC) was generated from a 735-bp PvuII fragment of VP intron I subcloned into pGEM-3 and linearized by HindIII. High specific activity antisense complementary RNA probes for CRHin, CRHex, VPin, and VPex were produced using [35S]ATP and [35S]UTP as previously described (28). In situ hybridization was performed as previously described (28). Briefly, before hybridization, sections were air-dried at room temperature, fixed with 4% formaldehyde for 5 min at room temperature, washed three times with PBS, and then acetylated in 0.25% acetic anhydride in 0.1 M triethanolamine-0.9% NaCl (pH 8.0) for 10 min at room temperature. Sections were transferred through 70% (1 min), 80% (1 min), 95% (2 min), and 100% ethanol (1 min); 100% chloroform (5 min); and 100% (1 min) and 95% ethanol (1 min) and dried. Sections were hybridized overnight at 55 C with 2 x 106 cpm labeled CRHin, CRHex, VPex, or VPin probe per slide containing four sections, respectively. Nonspecifically hybridized probe was removed by washing with 50% formamide-250 mM NaCl at 60 C for 10–15 min and ribonuclease A treatment for 30 min at 37 C, followed by three washes with 0.1 x SSC (standard saline citrate) at 50 C for 15 min. Finally, slides were dipped in 70% ethanol and air-dried before exposure to film. All control and experimental sections were hybridized at the same time.

Analysis and quantification
For quantification of CRH hnRNA and CRH mRNA in the PVN as well as VP hnRNA and VP mRNA in the magnocellular division of the PVN, sections were exposed to Kodak BIOMAX film (Eastman Kodak Co., Rochester, NY) together with 14C-labeled standards (American Radiochemical, St. Louis, MO) for 10 h (CRHex), 15 days (CRHin), 20 min (VP mRNA), and 40 h (VP hnRNA). For cellular localization of VP and CRH hybrids, slides were subsequently dipped in nuclear emulsion diluted 1:1 in distilled water (NTB2, Eastman Kodak Co.), exposed for appropriate times (CRHin, 40 days; CRHex, 3 days; VPex, 12 days; VPin, 42 days) and counterstained with cresyl violet acetate (Sigma Chemical Co.). The optical density of film autoradiographic images of parvocellular CRH mRNA and CRH hnRNA as well as magnocellular VP hnRNA and mRNA in the PVN and supraoptic nuclei (SON) were measured in a computerized image analysis system (Imaging Research, Inc., St. Catherine, Canada), using the public domain NIH Image program (developed at the NIH and available over the internet at: http://rsb.info.nih.gov/nih-image). Optical densities obtained in two consecutive sections per rat were averaged and used to calculate group means. The results are presented as the mean and SE of the percent change from the basal level in naive rats. Analysis of grain density levels of VP hnRNA and mRNA and of the number of cells containing VP hnRNA and VP mRNA in the medial parvocellular of the PVN was carried out in the cresyl violet-counterstained sections using a x40 objective with brightfield condenser as previously described (9, 16). Medial parvocellular VP neurons in the PVN were differentiated histologically from magnocellular neurons on the basis of their overall size, their relatively low level of VP expression, and their small, dense-staining nuclei. The relative grain density levels of VP hnRNA and VP mRNA were quantified in the medial parvocellular subdivision of PVN using computerized densitometry, as described above, after subtracting background from the proximity of the measured cells. The grain density measurements for parvocellular VP hnRNA and VP mRNA were made on individual cells identified as parvocellular after excluding scattered magnocellular cells in the medial parvocellular subdivision of the PVN. For each animal, at least two sections were measured bilaterally, and the average value for each rat was used to calculate group means. The results of grain density measurements are presented as the mean and SE of the percent change from the basal level in naive rats.

Statistical analysis was performed by one-way ANOVA, followed by Fisher’s least significant difference procedure (PLSD) test to assess statistical significance between control and experimental groups at each time point. P < 0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Plasma corticosterone responses
Fourteen days of daily restraint had no effect on basal plasma corticosterone levels (24 h after the last restraint), and as previously reported the increase in plasma corticosterone after the last restraint was significantly lower than the response of naive rats (10). However, plasma corticosterone responses to the novel stress, ipHS, in RR rats were similar to those in naive control rats at most time points. The increase in plasma corticosterone in response to ipHS at 2 h was significantly higher in RR rats (Fig. 1Go).



View larger version (48K):
[in this window]
[in a new window]
 
Figure 1. Response of corticosterone to an acute homotypic restraint or ipHS (HS) injection in naive rats or rats subjected to repeated restraint for 14 days (restraint x 14). Both naive and RR rats were killed 15, 60, 120, and 240 min after ipHS on day 15. Additional groups of naive and RR rats were restrained for 60 min and killed immediately. Values are presented as the mean ± SE. **, P < 0.01 compared with basal naive; {star}{star}, P < 0.01 compared with basal restraint x 14; #, P < 0.05 compared with 120 min naive HS; {star}, P < 0.05 compared with basal restraint x 14; **, P < 0.01 compared with 60 min of naive restraint (by one-way ANOVA followed by Fisher’s PLSD test).

 
CRH hnRNA and CRH mRNA responses
Expression of CRH hnRNA in the PVN under resting conditions is extremely low. Consistent with a previous study (15), CRH hnRNA levels in the PVN increased significantly after 60 min of restraint in naive rats (Fig. 1AGo), but were unaffected by daily restraint for 14 days, and transcripts failed to increase in response to the last restraint episode (Fig. 2BGo). However, the pattern of CRH hnRNA responses to a novel stress, ipHS, in RR rats was identical to that in naive rats, showing a marked increase at 15 min and returning to the basal level 1 h after acute HS injection (Figs. 2Go, C and D, and 3A).



View larger version (114K):
[in this window]
[in a new window]
 
Figure 2. Effect of an acute homotypic restraint or heterotypic ipHS (HS) stress on CRH hnRNA (A–D) and CRH mRNA (E–H) levels in the PVN in naive rats and rats subjected to 14 days of repeated restraint. Darkfield photographs were taken through the medial parvocellular subdivision of the PVN showing CRH hnRNA signals after 60 min of acute restraint in naive rats (A), after 60 min of acute restraint in RR rats (B), 15 min after single acute HS injection in naive rats (C), and 15 min after single acute HS injection in RR rats (D). CRH mRNA signals under normal resting conditions (E) in naive rats, 24 h after the last period of restraint in RR rats (F), 2 h after a single acute HS injection in naive rats (G), and 2 h after HS injection in RR rats (H). 3V, Third ventricle.

 
CRH mRNA levels after daily repeated restraint were similar to the basal level (Fig. 2Go, E and F) and did not change 1 h after acute restraint in naive or RR rats. For the changes in CRH hnRNA, in naive and RR rats CRH mRNA levels increased significantly 2 and 4 h after ipHS (Figs. 2Go, G and H, and 3B). The increase in CRH mRNA levels 2 h after ipHS in RR rats was significantly higher than the response in naive rats. (P < 0.05 vs. naive ipHS 2 h; Figs. 2Go, G and H, and 3B).

VP hnRNA and VP mRNA responses in the parvocellular PVN
Basal expression of VP hnRNA in the parvocellular neurons of the PVN in naive rats was very low (Fig. 4AGo) and was not affected by daily restraint for 14 days (Fig. 4BGo). Acute restraint resulted in a significant increase in the levels of parvocellular VP hnRNA and the number of parvocellular neurons containing VP hnRNA in both naive and RR rats. However, the increase tended to be smaller after repeated restraint. The number of parvocellular neurons containing VP hnRNA 1 h after the last period of restraint was about 38% smaller in RR rats than in naive rats (P < 0.05, by ANOVA), whereas the decrease in grain density reached statistical significance only when excluding the responses to ipHS (Fig. 5Go, A and B). The patterns of response of parvocellular VP hnRNA responses to the heterotypic stress (ipHS) were similar in naive and RR rats, starting to increase at 1 h and remaining significantly elevated up to 4 h after ipHS injection (Fig. 5Go, A and B). However, the levels of parvocellular VP hnRNA and the number of parvocellular cells containing VP hnRNA were significantly higher 60 min after injection in RR rats compared with those in naive rats (Fig. 4Go, C and D, and Fig. 5Go, A and B).



View larger version (174K):
[in this window]
[in a new window]
 
Figure 4. Effect of an acute homotypic restraint or heterotypic ipHS (HS) stress on VP hnRNA levels in parvocellular neurons of the hypothalamic PVN in naive rats or rats subjected to repeated restraint for 14 days. Darkfield photographs were taken through the parvocellular subdivision of the PVN showing signals under resting conditions (A), 24 h after last period of restraint in RR rats (B), after 60 min of acute restraint in naive rats (C), 60 min after the onset of the last period of restraint in RR rats (D), 60 min after a single acute HS injection in naive rats (E), and 60 min after a single acute HS injection in RR rats (F). 3V, Third ventricle; PM, posterior magnocellular subdivision of the PVN; MP, medial parvocellular subdivision of the PVN.

 


View larger version (35K):
[in this window]
[in a new window]
 
Figure 5. The levels of VP hnRNA (A) and the number of parvocellular neurons containing VP hnRNA (B) in the parvocellular subdivision of the PVN (parvoVP hnRNA and parvoVP mRNA) in response to an acute homotypic restraint or a heterotypic ipHS (HS) injection stress in naive rats or rats subjected to repeated restraint for 14 days (restraint x 14). *, P < 0.05 compared with basal naive; **, P < 0.01 compared with basal naive; #, P < 0.05 compared with basal restraint x 14; ##, P < 0.01 compared with basal restraint x 14; +, P < 0.05 compared with 60 min of naive HS; 2+, P < 0.01 compared with 60 min of naive ipHS; {star}, P < 0.05 compared with 60 min of naive restraint. The results of parvoVP hnRNA levels are presented as the mean ± SE percent change from the basal naive value (by one-way ANOVA followed by Fisher’s PLSD test).

 
Basal VP mRNA levels in the parvocellular neurons of the PVN were very low under unstressed conditions (Fig. 6AGo). Daily repeated restraint for 14 days increased basal levels of VP mRNA and the number of parvocellular neurons containing VP mRNA (Fig. 6BGo). IpHS injection increased VP mRNA grain density levels by 4 h in naive rats (P < 0.05 vs. naive basal) and caused a further increase from the already elevated basal levels at 2 and 4 h in RR rats (P < 0.01 vs. naive ipHS at 2 or 4 h) (Figs. 6Go, C and D, and 7). The number of parvocellular neurons containing VP mRNA increased by 43.9% at 1 h and remained at 231.1% and 336.5% of the basal levels from 2–4 h after ipHS in naive rats (Fig. 7Go). Similar to VP mRNA grain density, the number of parvocellular neurons containing VP mRNA increased significantly over the already elevated basal levels in RR rats 2 and 4 h after ipHS (P < 0.05 vs. naive ipHS at 2 or 4 h).



View larger version (165K):
[in this window]
[in a new window]
 
Figure 6. Effect of an acute homotypic restraint or heterotypic ipHS (HS) injection on VP mRNA levels in the parvocellular neurons of the hypothalamic PVN in naive rats or rats subjected to repeated restraint for 14 days. Darkfield photographs were taken through the parvocellular subdivision of the PVN showing signals under resting conditions (A), 24 h after the last period of restraint in RR rats (B), 4 h after a single acute HS injection in naive rats (C), and 4 h after a single acute HS injection in RR rats (D). 3V, Third ventricle; PM, posterior magnocellular subdivision of the PVN; MP, medial parvocellular subdivision of the PVN.

 


View larger version (40K):
[in this window]
[in a new window]
 
Figure 7. The level of VP mRNA (A) and the number of parvocellular neurons containing VP mRNA (B) in the parvocellular subdivision of the PVN (parvoVP mRNA) in response to an acute homotypic restraint or heterotypic ipHS (HS) injection in naive rats and rats subjected to repeated restraint for 14 days (restraint x 14). *, P < 0.05 compared with basal naive; **, P < 0.01 compared with basal naive; #, P < 0.05 compared with basal restraint x 14; ##, P < 0.01 compared with basal restraint x 14; +, P < 0.05 compared with 120 min of naive HS; 2+, P < 0.01 compared with 120 min of naive HS; {star}, P < 0.05 compared with 240 min of naive HS; {star}{star}, P < 0.01 compared with 240 min of naive HS; **, P < 0.01 compared with 60 min of naive restraint. The results of parvoVP mRNA levels are presented as the mean ± SE percent change from basal naive levels (by one-way ANOVA followed by Fisher’s PLSD test).

 
VP hnRNA and VP mRNA responses in magnocellular neurons
Levels of magnocellular VP hnRNA or VP mRNA did not show any change in response to acute or repeated restraint in either PVN or SON magnocellular neurons. In both naive and RR rats, ipHS caused marked increases in VP hnRNA levels in the PVN and SON at all time points measured (Figs. 8AGo and 9AGo). Although the patterns of response were similar, the increase in VP mRNA levels in RR rats was significantly higher than that in naive rats 1 h after the injection (P < 0.05 vs. naive ipHS at 1 h). No significant changes in magnocellular VP mRNA in response to ipHS were found at any time point in naive rats, whereas in RR rats there was a small increase in both the PVN and SON, which reached statistical significance 2 h after ipHS (P < 0.05 vs. naive ipHS at 2 h; (Figs. 8BGo and 9BGo).



View larger version (42K):
[in this window]
[in a new window]
 
Figure 8. Levels of VP hnRNA (A) and VP mRNA (B) in the posterior magnocellular subdivision of PVN (pmVP hnRNA or mRNA) in response to an acute homotypic restraint or heterotypic ipHS (HS) injection in naive rats or rats subjected to repeated restraint for 14 days (restraint x 14). **, P < 0.01 compared with basal naive; ##, P < 0.01 compared with basal restraint x 14; {star}, P < 0.01 compared with 60 min of naive HS; *, P < 0.05 compared basal restraint x 14. The results are presented as the mean SE percent change from basal naive values (by one-way ANOVA followed by Fisher’s PLSD test).

 


View larger version (40K):
[in this window]
[in a new window]
 
Figure 9. Levels of VP hnRNA (A) and mRNA (B) in the SON (VP hnRNA and mRNA) in response to an acute homotypic restraint or heterotypic ipHS (HS) injection in naive rats and rats subjected to repeated restraint for 14 days (restraint x 14). **, P < 0.01 compared with basal naive; ##, P < 0.01 compared with basal restraint x 14; **, P < 0.01 compared with 60 min of naive HS; {star}, P < 0.05 compared with 120 min of naive HS. The results are presented as the mean ± SE percent change from basal naive values (by one-way ANOVA followed by Fisher’s PLSD test).

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
It has been shown that repeated restraint results not only in an adaptation of ACTH and corticosterone responses in the blood, but also to a loss of the CRH hnRNA and mRNA responses to the homotypic stressor (3, 10). Despite this, VP hnRNA and mRNA responses were preserved and indeed increased (10, 29). There is good evidence that when adaptation to a repeated stressor occurs there is preservation or even sensitization of the hormonal response to a heterotypic stress (3, 4, 21, 24, 30, 31). This suggests that the hypothalamus is able to differentiate between different types of stress and modify its response in the light of its previous experience. We therefore designed the current study to investigate how, at the hypothalamic level, the neuroendocrine neurons that have adapted to repeated episodes of restraint stress respond to a novel stress, the ip injection of HS.

The ip injection of HS into control animals resulted in a rapid activation of the HPA axis, with a 5-fold increase in plasma corticosterone within 15 min and peak levels at about 2 h. This is associated with a rapid increase in CRH hnRNA, which returns to normal levels by 1 h, and a more gradual increase in CRH mRNA, which peaks at 2 h. VP transcripts responded in a different time frame, with no change in hnRNA at 15 min, a peak response at 2 h, and levels still raised at 4 h. Not only are there changes in the prevalence of VP transcripts in the parvocellular PVN, but there is also a massive increase in the number of parvocellular cells that contain VP hnRNA and mRNA transcripts. It is well recognized that the cells containing VP in the parvocellular PVN represent one population of CRH neurons in which CRH and VP coexist, whereas there is a second population in which CRH exists alone (5). It has previously been described that adrenalectomy (32) or repeated stress (17, 18, 19, 33) results in an increased proportion of CRH cells that coproduce VP. The present demonstration of rapid increases in the number of parvocellular neurons expressing VP after a single ipHS injection suggests that the division of these cells into two separate populations is somewhat artificial, as most, and maybe all, CRH cells can cosynthesize VP in the appropriate circumstances. Thus, the proportion of cells falling into each population probably depends on the sensitivity of the methodology for detecting VP transcripts or peptide.

After 2 weeks of restraint stress there was no change in basal corticosterone, CRH hnRNA, CRH mRNA, or VP hnRNA. There was, however, a very marked increase in both VP mRNA and the number of cells containing VP mRNA. This is consistent with previous studies showing that parvocellular VP mRNA levels rise significantly after repeated immobilization or restraint (14, 19, 29) or repeated foot shock (34). Studies examining CRH and VP peptides have shown that daily repeated immobilization did not affect irCRH stores, but resulted in a progressive increase in VP stores and in the number of CRH nerve endings containing VP in the external zone of the median eminence (33). A further study showed that the VP content in the external zone of the median eminence increased to 160–190% of the control value, but the CRH content remained unchanged (35). In addition, the rate of release of immunoreactive VP from median eminence terminals increased in response to repeated or chronic stress (18, 35). Even more, the transient activation of hypothalamic CRH neurons by a single stressor resulted in a long lasting increase in VP coexpression regardless of the nature of the stressor, which in most cases was not accompanied by changes in CRH (36). Our present data showing an increase in the number of cells with detectable VP mRNA further demonstrates the flexibility of the neurochemical repertoire of these neurons. This change is selective for the parvocellular neurons, as there was no change in basal levels of VP mRNA in the magnocellular neurons of either the PVN or the SON.

Although the present study shows changes in CRH and VP expression at a single time point (60 min), the data confirmed our previous multitime point study (29) that showed that repeated restraint results in adaptation of the CRH transcript response but maintained VP responses to a subsequent episode of restraint. When rats from the same experimental group underwent the heterotypic stress of ipHS injection, CRH hnRNA and mRNA responses, far from being depressed, were very robust, and the peak response of both was greater than that seen in the control naive rats. Parvocellular VP hnRNA responded with a different, and delayed, time course, but again the peak levels achieved were greater than those in the control animals. VP hnRNA also reached peak levels earlier in the RR animals than in the controls. VP mRNA, despite starting at much higher prevalence in the RR animals, increased in a similar proportion to that in the control rats, achieving much higher absolute levels, which were still rising at 4 h. Both control and RR rats showed a similar increase in the number of parvocellular PVN cells containing VP hnRNA transcripts, but the relative increase in the number of cells expressing VP mRNA was greater for the control rats, as the RR animals started from a higher basal level.

The different time courses of CRH and VP transcript responses clearly imply different regulatory mechanisms for the transcription of these genes, as has been suggested in previous studies (17, 36, 37, 38). Differential sensitivity to corticosterone feedback (8, 39), second messengers, and transcription factors (38) may all be involved. The demonstration that there is adaptation of CRH, but not VP, parvocellular neuronal responses to repeated restraint confirms previous observations (10) and provides further evidence that VP is an important mediator of HPA axis activity during repeated stress (3, 4, 14, 17, 21, 33, 40, 41). Furthermore, it is clear from these experiments that animals that have adapted to RR stress maintain normal or increased CRH hnRNA and mRNA responses to a heterotypic stressor. The differential responses of the parvocellular neuron to the repeated homotypic stress and the novel heterotypic stimulus suggest the activation of distinct stimulatory and inhibitory pathways by the different stressors. It is possible that adaptation to the repeated homotypic stress is due to desensitization of the afferent pathways to the PVN at the synaptic levels or at the parvocellular neuron itself, and that the novel stress uses different pathways and neurotransmitters. However, despite the habituation, there is little evidence of desensitization, as VP responses to the repeated stress are preserved (29), and microdialysis experiments have shown that norepinephrine turnover in the PVN is increased, rather than decreased, during repeated immobilization (42). In contrast to restraint, the novel stress used in these experiments, ipHS, does not cause habituation of the HPA axis response to the repeated stimulus (11, 23, 27), arguing for different pathways. Facilitation of the HPA axis response has actually been described for a variety of stress combinations regardless of the ability of the repeated or novel stimulus to cause adaptation during repeated exposure (3, 22, 25), suggesting that the mechanisms of differential responses are more complex than simply different pathways and neurotransmitters.

Stimulatory stressful information is conveyed to the PVN through ascending catecholaminergic projections from the brain stem (43, 44). In addition, studies based on intermediate early gene expression, retrograde tracer, and lesioning of selective pathways have revealed that somatosensory/nociceptive stressors, such as restraint, immobilization, foot shock, social defeat, and forced swim (and probably ipHS), activate limbic areas in the brain, including the hippocampus, neocortical areas, amygdala, bed nucleus of the stria terminalis, and some hypothalamic and thalamic nuclei (45, 46). This limbic pattern of activation is similar, although not identical, for the different somatosensory stressors, but it differs markedly from the transmission paths of potentially life-threatening systemic stressors, such as metabolic, cardiovascular, respiratory, and immune stimuli, directly from the brain stem to the PVN (47, 48). The limbic structures activated by somatosensory stressors all have direct or indirect connections to the PVN and contain {gamma}-aminobutyl acidergic neurons known to inhibit the HPA axis (48). Lesions of the prefrontal cortex, hippocampus, central amygdala, have been reported to potentiate HPA axis responses to somatosensory stressors, supporting the idea that responses to this type of stressor can be modulated by limbic inhibitory circuitry (48). One possible pathway involved in the increased responsiveness to the heterotypic stressor is the parabrachial-posterior paraventricular thalamus-amygdala parvocellular paraventricular hypothalamus pathway, as lesions of the posterior paraventricular nucleus of the thalamus increase ACTH responses to restraint in previously chronically stressed animals, but not in naive animals (25). Influences from hypothalamic nuclei, such as the arcuate, ventromedial hypothalamic, and medial preoptic area, may also affect parvocellular neuronal activity during stress. In addition, other neurotransmitters and neuropeptides, including CRH itself, could modulate PVN activity through these pathways. Thus, processing and integration of somatosensory/nociceptive stimuli in the limbic system could activate or suppress inhibitory pathways to the PVN, enhancing or inhibiting parvocellular neuron responses depending on previous experiences and the type of stimulus. The exact mechanisms of the differential responses to homotypic and heterotypic stressors remain to be elucidated, but our data would certainly suggest that the neurotransmitter repertoire (and pathways) activated by different forms of stressor must be distinct enough to be distinguished by the stress-responsive cells in the parvocellular PVN.

Consistent with previous studies (49), VP hnRNA in the magnocellular division of the PVN and SON also increased markedly after HS, but no changes in VP mRNA were detected at any time point after HS injection in the control rats. This is probably due to the masking effect of the very large pool of VP mRNA in these neurons, so that significant changes can be observed only after longer periods of osmotic stimulation (22). It is noteworthy that although acute or repeated restraint had no effect on magnocellular VP hnRNA or VP mRNA, the responses of both magnocellular PVN and SON neurons to ipHS were higher in RR than in naive control rats in terms of grain density. Although this effect was seen only at one time point, it suggests that a chronic physical psychological stress may change the sensitivity of magnocellular neurons to osmotic stimulation. The possible implications of such a mechanism in certain disorders, including idiopathic edema, are unclear.

In conclusion, we confirm that there is a desensitization of CRH, but not VP, transcription responses to repeated restraint and have demonstrated that animals adapted to a chronic homotypical stress show a greater response of CRH and VP gene transcription in the parvocellular PVN after a novel stress (HS injection). The hypothalamus clearly has the flexibility to adapt to homotypic stress while at the same time maintaining its ability to respond to novel stressors.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 3. The levels of CRH hnRNA (A) and mRNA (B) in the PVN in response to an acute homotypic restraint or heterotypic ipHS (HS) stress in naive rats and rats subjected to repeated restraint for 14 days (restraint x 14). Bars represent the mean and SE of the value obtained by in situ hybridization in five or six rats per group, expressed as the percent change from basal in naive rats. *, P < 0.05 compared with basal naive; **, P < 0.01 compared with basal naive, ##, P < 0.01 compared with basal restraint x 14; {star}, P < 0.05 compared with 120 min naive HS (by one-way ANOVA followed by Fisher’s PLSD test).

 

    Footnotes
 
1 Present address: Department of Neuroscience, Johns Hopkins University, Baltimore, Maryland 21205. Back

Received December 29, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Antoni FA 1993 Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 14:76–122[CrossRef][Medline]
  2. Gilles G, Linton EA, Lowry PF 1982 Corticotropin-releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299:355–357[CrossRef][Medline]
  3. Aguilera G 1994 Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 15:321–350[CrossRef][Medline]
  4. Aguilera G 1998 Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol Metab 9:329–336[Medline]
  5. Whitnall MH, Smyth D, Gainer H 1987 Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats. Neuroendocrinology 45:420–424[Medline]
  6. Fremeau RT, Lundblad JR, Princhett DB, Wilcox JN, Roberts JL 1986 Regulation of proopiomelanocortin gene transcription in individual cell nuclei. Science 234:1265–1269[Abstract/Free Full Text]
  7. Herman JP, Schafer MKH, Thompson RC, Watson SL 1992 rapid regulation of corticotropin releasing hormone gene transcription in vivo. Mol Endocrinol 6:1061–1069[Abstract]
  8. Kovacs KJ, Sawchenko PE 1996 Sequence of stress induced alterations in indices of synaptic and transcriptional activation in parvocellular secretory neurons. J Neurosci 16:262–273[Abstract/Free Full Text]
  9. Ma X-M, Levy A, Lightman SL 1997 Rapid changes in heteronuclear RNA for corticotropin-releasing hormone and arginine vasopressin in response to acute stress. J Endocrinol 152:81–89[Abstract]
  10. Ma X-M, Lightman SL 1998 The arginine vasopressin and corticotrophin-releasing hormone gene transcription responses to varied frequencies of repeated stress in rats. J Physiol 510:605–614[Abstract/Free Full Text]
  11. Ma X-M, Aguilera G 1999 Transcriptional responses of the vasopressin and corticotropin releasing hormone genes to acute and repeated intraperitoneal hypertonic saline injection in rats. Mol Brain Res 68:129–140[Medline]
  12. Harbuz MS, Lightman SL 1989 Responses of hypothalamic and pituitary mRNA to physical and physiological stress in the rat. J Endocrinol 122:705–711[Abstract]
  13. Bartanusz V, Aubry J-M, Jevoza D, Baffi J, Kiss JZ 1993 Up-regulation of vasopressin mRNA in paraventricular hypophysiotrophic neurons after acute immobilization stress. Neuroendocrinology 58:625–629[Medline]
  14. Makino S, Smith MA, Gold PW 1995 Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels. Endocrinology 136:3299–3309[Abstract]
  15. Imaki T, Wang X-Q, Shibasaki T, Yamada K, Harada S, Chikada N, Naruse M, Demura H 1995 Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoid in rats. J Clin Invest 96:231–238
  16. Herman JP 1995 In situ hybridization analysis of vasopressin gene transcription in the paraventricular and supraoptic nuclei of the rat: regulation by stress and glucocorticoids. J Comp Neurol 363:15–27[CrossRef][Medline]
  17. De Goeij DCE, Jezova D, Tilders FJH 1992 Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res 577:165–168[CrossRef][Medline]
  18. De Goeij DCE, Binnekade R, Tilders FJH 1992 Chronic stress enhances vasopressin but not corticotropin-releasing factor secretion during hypoglycemia. Am J Physiol 263:E394–E399
  19. Bartanusz V, Jezova D, Bertini LT, Tilders FJH, Aubry JM, Kiss JZ 1993 Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 132:895–902[Abstract]
  20. Kant GJ, Lue JR, Anderson SM, Mougey EH 1987 Effects of chronic stress on plasma corticosterone, ACTH and prolactin. Physiol Behav 40:775–779[CrossRef][Medline]
  21. Hashimoto K, Suemaru S, Takao T, Sugawar M, Makino S, Ota Z 1988 Corticotropin-releasing hormone and pituitary adrenocortical responses in chronically stressed rat. Regul Pept 23:117–126[CrossRef][Medline]
  22. Dallman MF, Akana SF, Scribner KA, Bradbury MJ, Walker CD, Strack AM, Casio CS 1992 Stress, feedback and facilitation in the hypothalamus pituitary adrebnal axis. J Neuroendocrinol 4:517–526[CrossRef]
  23. Lightman SL, Young WS 1989 Influence of steroids on the hypothalamic corticotropin-releasing factor and proenkephalin mRNA responses to stress. Proc Natl Acad Sci USA 86:4303–4310
  24. Marti O, Gavaldà A, Gmez F, Armario A 1994 Direct evidence for chronic stress induced facilitation of the adrenocorticotropin response to a novel acute stressor. Neuroendocrinolgy 60:1–7[Medline]
  25. Bhatnagar S, Dallman M 1998 Neuroanatomical basis for facilitation of hypothalamic-pituitary-adrenal responses to a novel stressor after chronic stress. Neuroscience 84:1025–39[CrossRef][Medline]
  26. Lightman SL, Young III WS 1987 Vasopressin, oxytocin, dynorphin, enkephalin and corticotropin-releasing factor mRNA stimulation in the rat. J Physiol 394:23–39[Abstract/Free Full Text]
  27. Kiss A, Aguilera G 1993 Regulation of the hypothalamic pituitary adrenal axis during chronic stress: responses to repeated intraperitoneal hypertonic saline injection. Brain Res 630:262–270[CrossRef][Medline]
  28. Luo X, Kiss A, Makara GB, Lolait SJ, Aguilera G 1994 Stress specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and suraopic nuclei of the hypothalamusin the rat. J Neuroendocrinol 6:689–696[CrossRef][Medline]
  29. Ma X-M, Levy A, Lightman SL 1997 Emergence of an isolated VP response to stress following repeated restraint: a study of both VP and CRH mRNA and hnRNA. Endocrinology 138:4351–4357[Abstract/Free Full Text]
  30. Vernikos J, Dallman MF, Bonner C, Katzen A, Shinsako J 1982 Pituitary-adrenal function in rats chronically exposed to cold. Endocrinology 110:413–420[Abstract]
  31. Dhabhar FS, McEwen BS, Spencer RL 1997 Adaptation to prolonged or repeated stress-comparison between rat strains showing intrinsic differences in reactivity to acute stress. Neuroendocrinology 65:360–368[Medline]
  32. Wolfson B, Manning RW, Davis LG, Arentzen R, Baldino Jr F 1985 Co-localization of corticotropin-releasing factor and vasopressin mRNA in neurons after adrenalectomy. Nature 315:59–61[CrossRef][Medline]
  33. De Goeij DCE, Kvetnansky R, Whitnall MH, Jezova D, Berkenbosch F, Tilders FJH 1991 Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin releasing factor neurons in the median eminence of rats. Neuroendocrinology 53:150–159[Medline]
  34. Sawchenko PE, Arias CA, Mortrud MT 1993 Local tetrodoxin blocks chronic stress effects on corticotropin-releasing factor and vasopressin messenger ribonucleic acid in hypophysiotropic neurons. J Neuroendocrinol 5:341–348[CrossRef][Medline]
  35. Tilders FJH, Schmidt ED, De Goeij DCE 1993 Phenotypic plasticity of CRF neurons during stress. Ann NY Acad Sci 697:39–52[Medline]
  36. Schmidt ED, Janszen JW, Binnekade R, Tilders FJH 1997 Transient suppression of resting corticosterone levels induces sustained increase of VP stores in hypothalamic CRH-neurons of rats. J Neuroendocrinol 9:69–77[CrossRef][Medline]
  37. Herman JP, Wiegand SJ, Watson SJ 1990 Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations. Endocrinology 127:2408–2417[Abstract]
  38. Kovács KJ Arias C, Sawchenko PE 1998 Protein synthesis blockade differentially affects the stress-induced transcriptional activation of neuropeptide genes in parvocellular neurosecretory neurons. Mol Brain Res 54:85–91[Medline]
  39. Ma X-M, Levy A, Lightman SL 1997 Rapid changes of heteronuclear RNA for arginine vasopressin but not for corticotropin-releasing hormone in response to acute corticosterone administration. J Neuroendocrinol 9:723–728[CrossRef][Medline]
  40. Scaccianoce S, Muscolo LAA, Cigliana G, Navarra D, Nicolai R, Angelucci L 1991 Evidence for a specific role of vasopressin in sustaining pituitary-adrenocortical stress response in the rat. Endocrinology 128:3138–3143[Abstract]
  41. Chowdrey HS, larsen PJ, Harbuz MS, Jessop DS, Aguilera G, Eckland DJ, Lightman SL 1995 Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. Br J Pharmacol 116:2417–2424[Medline]
  42. Pakac K, Armando I, Fukuhara K, Kvetnansky R, Palkovits M, Goldstein DS 1992 Noradrenergic activation of the paraventricular nucleus during acute and chronic immobilization stress in rats: an in vivo microdialysis study. Brain Res 589:91–96[CrossRef][Medline]
  43. Swanson LW, Simmonds DM 1989 Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemistry study in the rat. J Comp Neurol 285:413–435[CrossRef][Medline]
  44. Palkovits M, Mezey E, Skirboll L, Hokfelt T 1992 Adrenergic projections from the lower brain stem to the hypothalamic paraventricular nucleus, the lateral hypothalamic area and the central nucleus of the amygdala. J Chem Neuroanat 5:407–415[CrossRef][Medline]
  45. Cullinan WE, Herman JP, Battaglia DF, Akil H, Watson SJ 1994 Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience 64:4 77–505
  46. Li H-Y, Erickson A, Sawchenko PE 1996 Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci USA 93:2359–2364[Abstract/Free Full Text]
  47. Sawchenko PE, Brown ER, Chan RKW, Erickson A, Li H-Y, Roland BL, Kovaks KJ 1996 The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. Prog Brain Res 107:201–222[Medline]
  48. Herman JP, Cullinan WE 1997 Neurocircutry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20:78–84[CrossRef][Medline]
  49. Herman JP, Ascäfer MK-H, Watson SJ, Sherman TG 1991 In situ hybridization analysis of arginine vasopressin gene transcription using intron-specific probes. Mol Endocrinol 5:1447–1456[Abstract]



This article has been cited by other articles:


Home page
EndocrinologyHome page
H. E. Bates, A. S. Sirek, M. A. Kiraly, J. T. Y. Yue, D. Goche Montes, S. G. Matthews, and M. Vranic
Adaptation to Mild, Intermittent Stress Delays Development of Hyperglycemia in the Zucker Diabetic Fatty Rat Independent of Food Intake: Role of Habituation of the Hypothalamic-Pituitary-Adrenal Axis
Endocrinology, June 1, 2008; 149(6): 2990 - 3001.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Yu, H. Chen, W. Zhao, S. G. Matta, and B. M. Sharp
Nicotine Self-Administration Differentially Regulates Hypothalamic Corticotropin-Releasing Factor and Arginine Vasopressin mRNAs and Facilitates Stress-Induced Neuronal Activation
J. Neurosci., March 12, 2008; 28(11): 2773 - 2782.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Wotus, M. M. Arnhold, and W. C. Engeland
Dehydration-induced drinking decreases Fos expression in hypothalamic paraventricular neurons expressing vasopressin but not corticotropin-releasing hormone
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1349 - R1358.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. J. Lolait, L. Q. Stewart, D. S. Jessop, W. S. Young 3rd, and A.-M. O'Carroll
The Hypothalamic-Pituitary-Adrenal Axis Response to Stress in Mice Lacking Functional Vasopressin V1b Receptors
Endocrinology, February 1, 2007; 148(2): 849 - 856.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. N. Richardson, E. P. Zorrilla, C. D. Mandyam, and C. L. Rivier
Exposure to Repetitive Versus Varied Stress during Prenatal Development Generates Two Distinct Anxiogenic and Neuroendocrine Profiles in Adulthood
Endocrinology, May 1, 2006; 147(5): 2506 - 2517.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Yue, N. Mutsuga, E. M. Scordalakes, and H. Gainer
Studies of oxytocin and vasopressin gene expression in the rat hypothalamus using exon- and intron-specific probes
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1233 - R1241.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Hayashi, H. Arima, M. Goto, R. Banno, M. Watanabe, I. Sato, H. Nagasaki, and Y. Oiso
Vasopressin gene transcription increases in response to decreases in plasma volume, but not to increases in plasma osmolality, in chronically dehydrated rats
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E213 - E217.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Viau, B. Bingham, J. Davis, P. Lee, and M. Wong
Gender and Puberty Interact on the Stress-Induced Activation of Parvocellular Neurosecretory Neurons and Corticotropin-Releasing Hormone Messenger Ribonucleic Acid Expression in the Rat
Endocrinology, January 1, 2005; 146(1): 137 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Houshyar, S. Manalo, and M. F. Dallman
Time-Dependent Alterations in mRNA Expression of Brain Neuropeptides Regulating Energy Balance and Hypothalamo-Pituitary-Adrenal Activity after Withdrawal from Intermittent Morphine Treatment
J. Neurosci., October 20, 2004; 24(42): 9414 - 9424.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Kondo, H. Arima, R. Banno, S. Kuwahara, I. Sato, and Y. Oiso
Osmoregulation of vasopressin release and gene transcription under acute and chronic hypovolemia in rats
Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E337 - E346.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
X.-M. Ma, J. Huang, Y. Wang, B. A. Eipper, and R. E. Mains
Kalirin, a Multifunctional Rho Guanine Nucleotide Exchange Factor, Is Necessary for Maintenance of Hippocampal Pyramidal Neuron Dendrites and Dendritic Spines
J. Neurosci., November 19, 2003; 23(33): 10593 - 10603.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Zelena, Z. Mergl, A. Foldes, K. J. Kovacs, Z. Toth, and G. B. Makara
Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint
Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1110 - E1117.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Viau, P. Lee, J. Sampson, and J. Wu
A Testicular Influence on Restraint-Induced Activation of Medial Parvocellular Neurons in the Paraventricular Nucleus in the Male Rat
Endocrinology, July 1, 2003; 144(7): 3067 - 3075.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. E. Kresse, M. Million, E. Saperas, and Y. Tache
Colitis induces CRF expression in hypothalamic magnocellular neurons and blunts CRF gene response to stress in rats
Am J Physiol Gastrointest Liver Physiol, November 1, 2001; 281(5): G1203 - G1213.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Kakiya, H. Arima, H. Yokoi, T. Murase, Y. Yambe, and Y. Oiso
Effects of acute hypotensive stimuli on arginine vasopressin gene transcription in the rat hypothalamus
Am J Physiol Endocrinol Metab, October 1, 2000; 279(4): E886 - E892.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available